Výsledky vyhledávání - "HBY 097/2001 Study Group"

Akademický článek

Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group.

Autor: Kleim JP; Clinical Virology Unit, Glaxo Wellcome, Stevenage, Herts SG1 2NY, United Kingdom. jpk49970@GlaxoWellcome.co.uk, Winters M, Dunkler A, Suarez JR, Riess G, Winkler I, Balzarini J, Oette D, Merigan TC

Publikováno v: The Journal of infectious diseases [J Infect Dis] 1999 Mar; Vol. 179 (3), pp. 709-13.

Zobrazit plný text záznamu

Autor: J P, Kleim, M, Winters, A, Dunkler, J R, Suarez, G, Riess, I, Winkler, J, Balzarini, D, Oette, T C, Merigan

Publikováno v: The Journal of infectious diseases. 179(3)

The safety and antiviral activity of the second-generation nonnucleoside inhibitor HBY 097 was investigated in asymptomatic or mildly symptomatic human immunodeficiency virus (HIV)-1-infected patients in a randomized, double-blinded, dose-escalation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9600d5b9e845cb2e6e4ac8398845e985
https://pubmed.ncbi.nlm.nih.gov/9952383

Zobrazit plný text záznamu

Akademický článek

Antiviral Activity of the Human Immunodeficiency Virus Type 1-Specific Nonnucleoside Reverse Transcriptase Inhibitor HBY 097 Alone and in Combination with Zidovudine in a Phase II Study

Autor: HBY 097/2001 Study Group, Kleim, Jörg-Peter, Winters, Mark, Dunkler, Anke, Suarez, José-Ramon, Rieβ, Günther, Winkler, Irvin, Balzarini, Jan, Oette, Dagmar, Merigan, Thomas C.

Publikováno v: The Journal of Infectious Diseases, 1999 Mar 01. 179(3), 709-713.

Externí odkaz: https://www.jstor.org/stable/30117329

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání